- Home
- TLPH vs DOMH Comparison
TLPH vs DOMH Comparison
Compare TLPH & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLPH
- DOMH
- Stock Information
- Founded
- TLPH 2005
- DOMH 1967
- Country
- TLPH United States
- DOMH United States
- Employees
- TLPH N/A
- DOMH N/A
- Industry
- TLPH Biotechnology: Pharmaceutical Preparations
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- TLPH Health Care
- DOMH Health Care
- Exchange
- TLPH Nasdaq
- DOMH Nasdaq
- Market Cap
- TLPH 13.4M
- DOMH 12.1M
- IPO Year
- TLPH 2011
- DOMH N/A
- Fundamental
- Price
- TLPH $0.74
- DOMH $1.64
- Analyst Decision
- TLPH Strong Buy
- DOMH
- Analyst Count
- TLPH 2
- DOMH 0
- Target Price
- TLPH $4.50
- DOMH N/A
- AVG Volume (30 Days)
- TLPH 67.4K
- DOMH 12.1K
- Earning Date
- TLPH 11-13-2024
- DOMH 11-08-2024
- Dividend Yield
- TLPH N/A
- DOMH N/A
- EPS Growth
- TLPH N/A
- DOMH N/A
- EPS
- TLPH N/A
- DOMH N/A
- Revenue
- TLPH $281,000.00
- DOMH $12,589,000.00
- Revenue This Year
- TLPH N/A
- DOMH N/A
- Revenue Next Year
- TLPH N/A
- DOMH N/A
- P/E Ratio
- TLPH N/A
- DOMH N/A
- Revenue Growth
- TLPH N/A
- DOMH 1117.50
- 52 Week Low
- TLPH $0.61
- DOMH $1.50
- 52 Week High
- TLPH $1.61
- DOMH $3.20
- Technical
- Relative Strength Index (RSI)
- TLPH 35.76
- DOMH 42.30
- Support Level
- TLPH $0.66
- DOMH $1.50
- Resistance Level
- TLPH $0.73
- DOMH $1.67
- Average True Range (ATR)
- TLPH 0.08
- DOMH 0.12
- MACD
- TLPH -0.02
- DOMH -0.00
- Stochastic Oscillator
- TLPH 15.55
- DOMH 32.60
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.